Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-008749
Filing Date
2014-05-12
Accepted
2014-05-12 17:07:01
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20140331_10q.htm 10-Q 835554
2 EXHIBIT 31.1 ex31-1.htm EX-31 16916
3 EXHIBIT 32.1 ex32-1.htm EX-32 7361
  Complete submission text file 0001437749-14-008749.txt   4524092

Data Files

Seq Description Document Type Size
4 EXHIBIT 101.INS bota-20140331.xml EX-101.INS 722351
5 EXHIBIT 101.SCH bota-20140331.xsd EX-101.SCH 34189
6 EXHIBIT 101.CAL bota-20140331_cal.xml EX-101.CAL 23452
7 EXHIBIT 101.DEF bota-20140331_def.xml EX-101.DEF 155130
8 EXHIBIT 101.LAB bota-20140331_lab.xml EX-101.LAB 244960
9 EXHIBIT 101.PRE bota-20140331_pre.xml EX-101.PRE 160850
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 14834248
SIC: 2836 Biological Products, (No Diagnostic Substances)